Skip to main
DRNA
DRNA logo

Dicerna Pharmaceuticals (DRNA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Dicerna Pharmaceuticals (DRNA) Stock

About Dicerna Pharmaceuticals (DRNA)

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded b...read more
Market cap$2.98B
Today's volume
Revenue (TTM)
Avg. daily volume2.73M
EBITDA (TTM)
Open
Price / earnings ratio-23.44x
Today's range
Debt / equity
52 week range$19.06 - $40.14
5 year debt / equity9.72x
Beta (LTM)0.98x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 9, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 19, 2025, the market cap for DRNA stock is $2.98B

The current P/E ratio for DRNA stock is -23.44

The 52-week high for DRNA stock is $40.14. The current DRNA stock price $undefined is 100.00% below its 52-week high

The 52-week low for DRNA stock is $19.06. The current DRNA stock price $undefined has increased 100.00% from its 52-week low

No, the DRNA stock does not pay dividends to its shareholders

How to buy DRNA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in DRNA stock

    Navigate to the Explore page. Then, type DRNA into the search bar. When you see DRNA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased DRNA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Dicerna Pharmaceuticals Stock Earnings

The value each DRNA share was expected to gain vs. the value that each DRNA share actually gained.

Dicerna Pharmaceuticals (DRNA) reported Q3 2021 earnings per share (EPS) of -$0.22, beating estimates of -$0.46 by 52.17%. In the same quarter last year, Dicerna Pharmaceuticals's earnings per share (EPS) was -$0.29. Dicerna Pharmaceuticals is expected to release next earnings on 11/09/2021, with an earnings per share (EPS) estimate of $0.

Buy Dicerna Pharmaceuticals (DRNA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.